SPECIFICS OF THE EARLY PHASES OF CLINICAL TRIALS: FROM SCIENCE TO PERSON
https://doi.org/10.15829/1560-4071-2015-9-76-79
Abstract
The article focuses on the form of ethical controversy of the new drugs studies on humans. The issue is at its most importance in early phases of clinical trials that resemble an experiment, therefore requiring specific regulation. Has the difficulties been resolved, that are related to ethical aspects of human participants in new drugs investigation? Are not there any aspects that require thorough interdisciplinary workout, but being covered by strict regulation? Authors try to answer these questions taking into account a biosocial nature of the object of investigations.
About the Authors
I. G. Gordeev
Russian National Research Medical University named after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
E. O. Taratukhin
Russian National Research Medical University named after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
References
1. Taratukhin EO. Patient’s personality: an interdisciplinary approach to cardiovascular pathology. Russ J Cardiol 2014; 9 (113): 22-25. Russian (Таратухин Е. О. Личность больного: междисциплинарный подход в работе с кардиологической патологией. Российский кардиологический журнал, 2014; 9: 22-25).
2. Gigerenzer G, Muir Gray JA (eds.). Better Doctors, Better Patients, Better Decisions. Envisioning Healthcare 2020. Strüngmann Forum Reports. London: MIT Press, 2011.
3. Glymour C. Causation and Statistical Inference. Glymour C., Beebee H. et al. (eds.). The Oxford Handbook of Causation. Oxford University Press, 2012: 498-519.
Review
For citations:
Gordeev I.G., Taratukhin E.O. SPECIFICS OF THE EARLY PHASES OF CLINICAL TRIALS: FROM SCIENCE TO PERSON. Russian Journal of Cardiology. 2015;(9):76-79. (In Russ.) https://doi.org/10.15829/1560-4071-2015-9-76-79
Views:
617
Email this article 